ClearCourse, a group of innovative technology brands providing software solutions and an integrated payments platform, has announced the acquisition of Blue Zinc.
Founded in 2002, Belfast based Blue Zinc provides solutions for the management of patient referrals, clinical pathways and clinics for the physical and mental health segments in the healthcare sector.
The company will form part of ClearCourse’s Business Services division and expand the latter’s growing footprint in the healthcare space.
The business has been operating in Australia since 2006 and recently acquired Collab IT, a software company that distributed its product suite in the region.
RELATED: Blue Zinc enters fast-growing therapist market with new practice management and admin platform
Based in Belfast, Blue Zinc shares key synergies with ClearCourse’s existing clinic management software businesses: e-clinic, PPM and Assisi.
The company’s integration with ClearCourse presents multiple benefits, including the opportunity to implement the proprietary payments platform ClearAccept and for Blue Zinc to grow with the investment and guidance of the ClearCourse team.
Blue Zinc’s next chapter will focus on expanding the company’s base of clients into global markets, while building new healthcare products. The business will also continue to support the efficient collection of clinical data, enabling international treatments to be continually developed and improved.
Following the deal, co-founders and current joint Managing Directors Kyle Lunn and Ronnie Johnston will continue with the company, overseeing Blue Zinc’s strategic direction.
RELATED: Blue Zinc launches portal to shift healthcare and rehabilitation journey for patients online
Gerry Gualtieri, CEO of ClearCourse, said: “Healthcare is one of the country’s most crucial sectors, and one in which we stand to see the most significant material benefits from tailored software and technology. Blue Zinc’s work across the MSK and mental health segments is a testament to this, with 1 in 4 individuals affected by 200 MSK different conditions which account for some 30% of GP consultations in England.”
Kyle Lunn, Managing Director of Blue Zinc, added: “Over the last twenty years, we are proud of becoming a valued and well-established provider of innovation across health technology, especially at a time when the demand for healthcare services is increasing exponentially. With ClearCourse’s support, we plan to scale and extend the services we provide to our existing clients, who play a vital role in the physical and mental wellbeing of patients worldwide, while bringing innovation to new areas of healthcare. This is an ambitious and thoroughly exciting prospect for our skilled team.”
Source: Written from press release.
